Prompt

What are the best free disease-area therapeutic landscape reports for learning about oncology and immunology pipelines?

Biotechnology / Therapeutics Biotech1 observationLast seen Jul 31, 2026

Latest observation

Jul 31, 2026OpenAI APIWeb search: off

If you want free, high-quality disease-area therapeutic landscape reports for oncology and immunology, the best sources are usually government agencies, major nonprofits, and a few publisher-sponsored landscape pages. They vary in depth, but these are the most useful starting points:

Best free sources

1. Cancer.gov / NCI (National Cancer Institute)

  • Best for: authoritative oncology pipeline context, biomarkers, mechanism classes, and trial landscape basics
  • Why it’s good: trustworthy, regularly updated educational and research-oriented content
  • Look for:
    • NCI drug/therapeutic summaries
    • PDQ cancer treatment overviews
    • Cancer immunotherapy resources
    • clinical trials and emerging science pages

2. ClinicalTrials.gov

  • Best for: directly seeing active oncology and immunology pipelines
  • Why it’s good: primary source for trial status, intervention types, indications, and sponsors
  • How to use it well: search by disease area + filter for:
    • Phase 1/2/3
    • recruiting/interventional
    • drug/biologic therapy
    • immune checkpoint, CAR-T, cytokine, antibody, etc.

3. FDA Oncology Center of Excellence / CBER resources

  • Best for: understanding what’s already approved and where the field is heading
  • Why it’s good: excellent for regulatory perspective and therapy classes
  • Useful for: antibody-drug conjugates, cell therapies, immunotherapies, biomarkers

4. NCI Cancer Currents and annual reports

  • Best for: readable summaries of the state of oncology research
  • Why it’s good: easier than raw trial data, often highlights major pipeline trends
  • Good for learning: emerging modalities, resistance mechanisms, combination strategies

5. NIH / NIAID (for immunology and immune-mediated disease)

  • Best for: immunology-focused therapeutic areas, immune mechanisms, translational research
  • Why it’s good: strong coverage of immune dysregulation, inflammation, vaccines, and infectious/autoimmune overlap
  • Look for: disease-specific pages on autoimmune disease, inflammation, and immunotherapy science

6. Nature Reviews / Review articles with free summaries

  • Best for: understanding pipeline trends at a high level
  • Why it’s good: many review abstracts and some full open-access reviews are excellent for therapeutic landscape framing
  • Search terms: “therapeutic landscape,” “drug development,” “oncology pipeline,” “immunology therapeutics,” “open access review”

7. Open-access conference reviews and white papers

  • Best for: the latest pipeline movement
  • Why it’s good: major meetings like ASCO, AACR, ESMO, and ACR often have free highlights or educational summaries
  • Look for: pipeline review sessions, landscape summaries, and “state of the field” slide decks

8. PhRMA / industry association reports

  • Best for: broad pipeline overviews, especially in oncology and immunology
  • Why it’s good: usually easy to read, often free, and geared toward drug development trends
  • Caveat: can be selective and optimistic

9. Specialty nonprofit foundations

  • Best for: disease-specific immunology landscapes
  • Examples: lupus, IBD, psoriasis, rheumatoid arthritis, MS foundations and societies
  • Why it’s good: often publish pipeline trackers or research roadmaps
  • Bonus: these can be more actionable than generic immunology content

If you want the most practical free combination

For a solid overview of both oncology and immunology pipelines, I’d start with:

  1. ClinicalTrials.gov for active pipeline mapping
  2. NCI for oncology landscape understanding
  3. NIAID/NIH for immunology landscape understanding
  4. FDA for approved therapy classes and regulatory trends
  5. Open-access review articles for synthesis and interpretation

Search tips

Use queries like:

  • “oncology therapeutic landscape review open access”
  • “immunology pipeline review open access”
  • “cancer immunotherapy landscape report pdf”
  • “autoimmune disease pipeline report pdf”
  • “ASCO pipeline landscape 2025”

If you want, I can also give you a curated list of specific free reports and links for:

  • oncology
  • immunology / autoimmune disease
  • or a combined shortlist of the 10 best PDFs/pages.

Observation history

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, Meta AI, Qwen.

How can brands improve their AEO?

Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.

Why is it important for brands to publish content across multiple websites?

Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.

Want this interpreted for your brand?

Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.